The company plans to add 322,000ft² of manufacturing space to the current facility, nearly doubling its existing size. The construction, commissioning and validation of the facility expansion and
The regulator’s decision was based on results of CheckMate-141, a phase 3, open-label, randomized trial testing of Opdivo in comparison to three of the most commonly used treatments
The JV will invest in a new company to be called Imutex. It will boost hVIVO’s commercial flu portfolio and expand its operations into mosquito-borne diseases, with the
The agency’s specific action date is not provided but is expected to happen before the end of this year. Lundbeck received a complete response letter in October 2014
Genomics is the study of the genome, a double string of DNA which features all the genes required to make and operate an organism. The company established collaborations
The study will start in the second quarter of this year at Memorial Sloan Kettering Cancer Center in New York. Clinical costs will be shared by the companies.
The orphan drug status to the drug, Epidiolex, entitles GW Pharmaceuticals to a seven-year exclusive market period. TSC is the third orphan indication that the company is targeting
AbbVie and CytomX will jointly develop and commercialize probody drug conjugates directed against CD71, which is highly expressed several solid and hematologic cancers. Under the deal, CytomX will
The agency placed the hold last month after elevated serum sodium levels were found in four patients who received the highest dose of 5 ug/kg. Cara Therapeutics’ analysis
Ceftobiprole is a broad-spectrum antibiotic for intravenous administration with bactericidal activity against certain Gram-positive and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus and susceptible Pseudomonas spp. Under the agreement,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.